SCHEMBL4920511

SCHEMBL4920511

COc1ccc2c(c1)CCC(C(=O)N1CCN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC1)C2

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 8/20 0.71
PIK3CD O00329 6/20 0.71
PIK3R1 P27986 6/20 0.71
PIK3CA P42336 6/20 0.71
KDM4E B2RXH2 5/20 0.65
ALDH1A1 P00352 4/20 0.65
LMNA P02545 3/20 0.59
HPGD P15428 2/20 0.59
HSD17B10 Q99714 2/20 0.59
MAPT P10636 1/20 0.59
CYP1A2 P05177 1/20 0.57
TOP2A P11388 1/20 0.57
CYP2C9 P11712 1/20 0.57
TOP2B Q02880 1/20 0.57
TDP1 Q9NUW8 2/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KMT2A Q03164 1/20 0.52
ATM Q13315 1/20 0.52
HRH3 Q9Y5N1 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4633000 0.91 PIK3CG (0.68) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E
SCHEMBL4633160 0.88 PIK3CG (0.69) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E
SCHEMBL4633027 0.87 KDM4E (0.56) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E
SCHEMBL4633103 0.84 KMT2A (0.51) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E
SCHEMBL4632270 0.83 PIK3CG (0.72) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E
SCHEMBL4717454 0.82 ALDH1A1 (0.73) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E
SCHEMBL10919718 0.81 KDM4E (0.80) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E
SCHEMBL4632188 0.80 PIK3CG (0.63) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E
SCHEMBL10809240 0.79 KDM4E (1.00) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E
SCHEMBL29350842 0.79 KDM4E (1.00) PIK3CGPIK3CDPIK3R1PIK3CAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139574-A1 Novel quinoline derivatives CADILA HEALTHCARE LIMITED 2008-06-12 US claimed
US-20080139574-A1 Novel quinoline derivatives CADILA HEALTHCARE LIMITED 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139574-A1 Novel quinoline derivatives UGT1A7, CYP3A5, CYP3A7 PIK3CG 3091/4885PIK3CD 1934/4885PIK3R1 3577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.